Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Acumen Pharmaceuticals to Showcase Advances in Alzheimer's Treatment at International Conference on Alzheimer’s and Parkinson’s Diseases 2026
-
Cross Keys Capital Advises SEPA Pain & Spine in Its Partnership with DxTx Pain & Spine
-
National Healthcare Properties Announces $64 million SHOP Acquisition
-
64% of Women Developers Say AI Has Increased Their Career Agency, BairesDev’s Survey Finds
-
Perceptyx Acquires Lyceum AI to Close the Gap Between Employee Experience and Learning and Development
-
Sironix Renewables Launches Furasoft™ – Next Generation, Bio-Based Surfactant for Personal Care
-
Byrna Technologies Announces CEO Transition
-
YETI Holdings, Inc. Announces Participation in Upcoming Investor Conferences
-
Annovis Announces Two Presentations at the AD/PD™ 2026 International Conference
-
Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates
-
Abundia Global Impact Group to Participate in Water Tower Research Fireside Chat on Wednesday, March 4, 2026
-
Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib
-
Upexi to Participate in Upcoming March Investor Conferences
-
PEDEVCO Announces 1-For-20 Reverse Stock Split
-
Arcutis Begins Enrolling Phase 1a/1b Study Evaluating ARQ-234, a CD200R Agonist, in Healthy Volunteers and Adults With Atopic Dermatitis
-
Discuss Introduces Real-Time AI Translation for Observers, Making Global Research Truly Universal
-
Comscore to Announce Fourth Quarter and Full Year 2025 Financial Results
-
Nanox Signs Distribution Agreement with Imperial Imaging Technology to Expand Nanox.ARC Access Across U.S. Southeast
-
Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT
-
Kratos Receives $7 Million Order for Counter-UAS Systems
-
Smart Buildings: Leveraging Sustainable AI to Reduce Carbon and Costs
-
Medidata’s Experience-based AI Earns Top Luminary Rating in Everest Group 2026 Review
-
Dateline Commences Music Valley Exploration Program
-
United States Antimony Corporation Announces Completion of Technical Report located in Ontario, Canada on Fostung Tungsten Deposit
-
Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community
-
Aspire Biopharma Partners with Microsize to Develop Rapid-delivery Sublingual Powder Formulation of Alprazolam for Faster Anxiety Relief
-
BK Technologies to Participate at the 38th Annual ROTH Conference
-
Babson Diagnostics Names Web Golinkin CEO
-
Click Media, a GameSquare Company, Wins Influencer Management Agency of the Year
-
T-knife Therapeutics Announces Authorization of Clinical Trial Application for TK-6302, A Multi-Armored, CRISPR based T cell Therapy for Solid Tumors
-
Ensysce Biosciences Announces First Peer-Reviewed Clinical Publication Demonstrating Oral Overdose Protection with MPAR(R) Technology
-
Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer
-
Elektros Inc. Secures U.S. Patent from the U.S. Patent and Trademark Office for Innovative Multi-Port Electric Vehicle Charging Technology
-
OMP Unveils Decision-Centric Planning to Accelerate Supply Chain Decision Velocity
-
Kyverna Therapeutics to Participate in Upcoming March Investor Conferences
-
Headwall Partners Announces Publication - "Headwall 2026 Steel & Metals Outlook Survey"
-
Gaudenzia Strengthens Integrated Treatment Model, Driving the Next Era of Recovery Care
-
Visual Edge IT Appoints Peter Stelling as Chief Operating Officer
-
Rocket Doctor Signs New Contract with Major U.S. Insurer, Expanding Access to an Additional 2.4 Million Members Across New York State
-
SUSE Strengthens Leadership Bench to Accelerate Innovation and Customer-Centric Solutions
-
Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Healthcare Forum
-
Pierre Fabre Pharmaceuticals Submits Type A Meeting Request to U.S. Food and Drug Administration (FDA) for Tabelecleucel Biologic License Application (BLA)
-
When Seconds Decide Outcomes: Audiebant Launches in the U.S. to Redefine Emergency Communication
-
Women-Led Financial Planning Department Joins Osaic from Commonwealth
-
Sonata Software Among the First Companies to Be Recognized as a Microsoft Frontier Partner
-
Advantmed Appoints Dr. Matt Lambert as Chief Medical Officer and Head of Product Strategy
-
Uni-Fuels Accelerates Global Growth with Nationwide Bunkering in Thailand
-
Koppers Management Participating in NYSE Materials Virtual Investor Access Day
-
Simulations Plus Convenes Industry and Regulatory Leaders to Define Responsible AI in MIDD
-
Antalpha Reports Fourth Quarter and Full Year 2025 Results
